Neoral absorption profiling: An evolution in effectiveness

[21] KAHAN BD, 1995, TRANSPLANTATION, V59, P505

[22] High variability of drug exposure: A biopharmaceutic risk factor for chronic rejection [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1639 - 1641

[23] Variable oral absorption of cyclosporine - A biopharmaceutical risk factor for chronic renal, allograft rejection [J]. TRANSPLANTATION, 1996, 62 (05) : 599 - 606

[24] Kahan BD, 1996, TRANSPLANT P, V28, P2143

[25] KAHAN BD, 1998, 17 WORLD C TRANSPL S

[26] Kelles A, 1999, Pediatr Transplant, V3, P282, DOI 10.1034/j.1399-3046.1999.00058.x

[27] Kelles A, 1996, TRANSPL INT, V9, P546

[28] Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation [J]. KIDNEY INTERNATIONAL, 1998, 54 (03) : 938 - 944

[29] Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies:: Report from the International Neoral® TDM Advisory Consensus Meeting (Vancouver, November 1997) [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1645 - 1649

[30] A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients [J]. TRANSPLANTATION, 1996, 62 (12) : 1744 - 1752

[21] KAHAN BD, 1995, TRANSPLANTATION, V59, P505

[22] High variability of drug exposure: A biopharmaceutic risk factor for chronic rejection [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1639 - 1641

[23] Variable oral absorption of cyclosporine - A biopharmaceutical risk factor for chronic renal, allograft rejection [J]. TRANSPLANTATION, 1996, 62 (05) : 599 - 606

[24] Kahan BD, 1996, TRANSPLANT P, V28, P2143

[25] KAHAN BD, 1998, 17 WORLD C TRANSPL S

[26] Kelles A, 1999, Pediatr Transplant, V3, P282, DOI 10.1034/j.1399-3046.1999.00058.x

[27] Kelles A, 1996, TRANSPL INT, V9, P546

[28] Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation [J]. KIDNEY INTERNATIONAL, 1998, 54 (03) : 938 - 944

[29] Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies:: Report from the International Neoral® TDM Advisory Consensus Meeting (Vancouver, November 1997) [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (05) : 1645 - 1649

[30] A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients [J]. TRANSPLANTATION, 1996, 62 (12) : 1744 - 1752